Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.

Source:http://linkedlifedata.com/resource/pubmed/id/20065185

J. Clin. Oncol. 2010 Feb 20 28 6 967-75

Download in:

View as

General Info

PMID
20065185